Division of Nuclear Medicine PET Radiopharmaceutical Production Program

Form 483FOIA Uncovered

Ann Arbor, Michigan, United StatesFEI 3010166888Issued March 07, 2019

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3010166888.

Observations4

Issue DateMarch 07, 2019

StatusNo Warning Letter

Related Inspections3

Establishment Details

Firm: Division of Nuclear Medicine PET Radiopharmaceutical Production Program
Location: Ann Arbor, Michigan, United States
FEI Number: 3010166888
Product Type: Drugs
Issue Date: March 07, 2019
Country: United States

Inspection History, 2014 to 2025

VAI2

OAI1

VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Division of Nuclear Medicine PET Radiopharmaceutical Production Program FDA Form 483, Ann Arbor, Michigan, March 7, 2019